Published in Stroke on November 01, 1999
Magnetic resonance imaging of glutamate. Nat Med (2012) 3.17
The role of extracellular adenosine in chemical neurotransmission in the hippocampus and Basal Ganglia: pharmacological and clinical aspects. Curr Top Med Chem (2011) 1.04
Production of leukotrienes in a model of focal cerebral ischaemia in the rat. Br J Pharmacol (2001) 1.03
Metabolic and transmitter changes in core and penumbra after middle cerebral artery occlusion in mice. Brain Res (2009) 1.01
Adenosine kinase determines the degree of brain injury after ischemic stroke in mice. J Cereb Blood Flow Metab (2011) 0.95
The role of ATP and adenosine in the brain under normoxic and ischemic conditions. Purinergic Signal (2007) 0.89
HIF-1 alpha is an essential effector for purine nucleoside-mediated neuroprotection against hypoxia in PC12 cells and primary cerebellar granule neurons. J Neurochem (2008) 0.87
Equilibrative nucleoside transporter ENT1 as a biomarker of Huntington disease. Neurobiol Dis (2016) 0.86
Dynamic metabolites profile of cerebral ischemia/reperfusion revealed by (1)H NMR-based metabolomics contributes to potential biomarkers. Int J Clin Exp Pathol (2014) 0.81
Time-course of protection by the selective A2A receptor antagonist SCH58261 after transient focal cerebral ischemia. Neurol Sci (2015) 0.80
Spreading depolarization-induced adenosine accumulation reflects metabolic status in vitro and in vivo. J Cereb Blood Flow Metab (2014) 0.80
Uneven distribution of nucleoside transporters and intracellular enzymatic degradation prevent transport of intact [14C] adenosine across the sheep choroid plexus epithelium as a monolayer in primary culture. Cerebrospinal Fluid Res (2006) 0.80
Anticonvulsant drugs, brain glutamate dehydrogenase activity and oxygen consumption. ISRN Pharmacol (2012) 0.76
Adenosine A2A receptors modulate acute injury and neuroinflammation in brain ischemia. Mediators Inflamm (2014) 0.76
Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man. Transl Stroke Res (2015) 0.76
Neuroprotective effects of adenosine deaminase in the striatum. J Cereb Blood Flow Metab (2016) 0.75
Invited Lectures : Overviews Purinergic signalling: past, present and future. Purinergic Signal (2006) 0.75
Metabolomic investigation of regional brain tissue dysfunctions induced by global cerebral ischemia. BMC Neurosci (2016) 0.75
Histological grading and staging of chronic hepatitis. J Hepatol (1995) 19.57
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology (2001) 6.88
A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke (2001) 5.81
Pattern of core and surface expression in liver tissue reflects state of specific immune response in hepatitis B. Lab Invest (1975) 2.97
Incident lacunes influence cognitive decline: the LADIS study. Neurology (2011) 2.81
Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem (2001) 2.63
Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl (2000) 2.56
Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology (2008) 2.41
Cortical networks for visual reaching: physiological and anatomical organization of frontal and parietal lobe arm regions. Cereb Cortex (1996) 2.17
Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation. Blood (1994) 2.16
Gastroepiploic artery free graft for coronary bypass. Eur J Cardiothorac Surg (1990) 1.94
A novel inward-rectifying K+ current with a cell-cycle dependence governs the resting potential of mammalian neuroblastoma cells. J Physiol (1995) 1.88
CT and MRI rating of white matter lesions. Cerebrovasc Dis (2002) 1.83
CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. Eur J Neurosci (2006) 1.80
Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J Biol Chem (1999) 1.80
[On the morphogenesis of eosinophilic single cell necrosis in the liver parenchyma of humans. Light and electron optical correlative studies]. Virchows Arch Pathol Anat Physiol Klin Med (1967) 1.77
Comparison of two methods for weaning patients with chronic obstructive pulmonary disease requiring mechanical ventilation for more than 15 days. Am J Respir Crit Care Med (2001) 1.75
Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. J Cardiovasc Electrophysiol (2000) 1.74
Motor patterns for human gait: backward versus forward locomotion. J Neurophysiol (1998) 1.68
Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J Biol Chem (2001) 1.67
Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohort. J Neurol Sci (2011) 1.66
Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study. Eur J Neurol (2009) 1.64
Pachydermodactyly: a case of an unusual type of reactive digital fibromatosis. Arch Dermatol (1993) 1.62
Representing spatial information for limb movement: role of area 5 in the monkey. Cereb Cortex (1996) 1.56
A2A-adenosine receptor reserve for coronary vasodilation. Circulation (1998) 1.55
Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. Lancet (2001) 1.55
Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their GATA-1 expression (GATA-1(low) mice). Blood (2001) 1.51
Effects of novelty and habituation on acetylcholine, GABA, and glutamate release from the frontal cortex and hippocampus of freely moving rats. Neuroscience (2001) 1.50
Why should I ventilate my patient with kyphoscoliosis? Monaldi Arch Chest Dis (2004) 1.47
White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease. Neurology (2004) 1.47
Kinematic determinants of human locomotion. J Physiol (1996) 1.47
The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis. Mult Scler (2009) 1.45
White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology (2010) 1.44
The A2A adenosine receptor mediates coronary vasodilation. J Pharmacol Exp Ther (1998) 1.40
Lung and respiratory muscle function at discharge from a respiratory intensive care unit. Monaldi Arch Chest Dis (2005) 1.39
[Portal venous thrombosis following splenectomy in portal hypertension: risks and management]. Schweiz Med Wochenschr (1993) 1.39
Detection of H2O and CO2 with distributed feedback diode lasers: measurement of broadening coefficients and assessment of the accuracy levels for volcanic monitoring. Appl Opt (1997) 1.39
Differences in spontaneous breathing pattern and mechanics in patients with severe COPD recovering from acute exacerbation. Eur Respir J (1999) 1.38
Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response. Gastroenterology (2001) 1.34
White matter changes and late-life depressive symptoms: longitudinal study. Br J Psychiatry (2007) 1.31
The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist. J Pharmacol Exp Ther (1996) 1.30
Tele-assistance in chronic respiratory failure patients: a randomised clinical trial. Eur Respir J (2008) 1.29
White matter changes in stroke patients. Relationship with stroke subtype and outcome. Eur Neurol (1999) 1.29
Deep frontal and periventricular age related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls: cross sectional results from the LADIS study. J Neurol Neurosurg Psychiatry (2009) 1.28
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome. Cell Death Dis (2011) 1.25
Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni. Liver (2000) 1.25
White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol (1998) 1.25
Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study. Diabet Med (2007) 1.25
The spectrum of Notch3 mutations in 28 Italian CADASIL families. J Neurol Neurosurg Psychiatry (2005) 1.19
Current trends in hardware and software for brain-computer interfaces (BCIs). J Neural Eng (2011) 1.19
Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur J Pharmacol (1984) 1.19
Functional consequences of ROMK mutants linked to antenatal Bartter's syndrome and implications for treatment. Hum Mol Genet (1998) 1.18
Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression. Cerebrovasc Dis (2008) 1.17
Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. Eur Respir J (1999) 1.17
Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study. Neurology (2012) 1.17
Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices. Br J Pharmacol (1999) 1.16
Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies. Clin Chim Acta (2012) 1.16
Effect of psychoactive drugs on the output of acetylcholine from the cerebral cortex of the cat. Eur J Pharmacol (1968) 1.15
Investigations into the acetylcholine output from the cerebral cortex of the cat in the presence of hyoscine. Br J Pharmacol Chemother (1967) 1.15
Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: implications for Alzheimer's disease. Neuroscience (2005) 1.14
Optimizing the P300-based brain-computer interface: current status, limitations and future directions. J Neural Eng (2011) 1.13
delta Antigen in hepatitis B: immunohistology of frozen and paraffin-embedded liver biopsies and relation to HBV infection. Hepatology (1981) 1.12
Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12
Left ventricular modelling: a quantitative functional assessment tool based on cardiac magnetic resonance imaging. Interface Focus (2011) 1.12
Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11
Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. Pharmacol Biochem Behav (1996) 1.11
Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma. Hepatology (2000) 1.10
Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study. J Neurol (2006) 1.10
IMP1/imp1: a gene involved in the nucleo-mitochondrial control of galactose fermentation in Saccharomyces cerevisiae. Genetics (1981) 1.09
Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults. Eur Respir J (2007) 1.08
Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08
Ursodeoxycholic acid treatment of primary hepatolithiasis in Caroli's syndrome. Lancet (1993) 1.07
Vesical dysfunction in systemic sclerosis (scleroderma) J Urol (1995) 1.07
CLH-3, a ClC-2 anion channel ortholog activated during meiotic maturation in C. elegans oocytes. Curr Biol (2001) 1.07
Prevalence of CT-detected cerebral abnormalities in an elderly Swedish population sample. Acta Neurol Scand (2008) 1.07
Neural basis for brain responses to TV commercials: a high-resolution EEG study. IEEE Trans Neural Syst Rehabil Eng (2008) 1.06
Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats. Br J Pharmacol (1996) 1.06
Is it really useful to repeat outpatient pulmonary rehabilitation programs in patients with chronic airway obstruction? A 2-year controlled study. Chest (2001) 1.05
Do glia have heart? Expression and functional role for ether-a-go-go currents in hippocampal astrocytes. J Neurosci (2000) 1.05
Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76 TeV. Phys Rev Lett (2011) 1.05
Myxoid dermatofibrosarcoma protuberans: morphological, ultrastructural and immunohistochemical features. J Cutan Pathol (1998) 1.05
M-15: high-affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus coeruleus, and spinal cord. Proc Natl Acad Sci U S A (1991) 1.05
Selective adenosine A2A receptor antagonists. Farmaco (2001) 1.05
Clinical significance of corpus callosum atrophy in a mixed elderly population. Neurobiol Aging (2006) 1.04
Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol (2006) 1.04
High resolution EEG hyperscanning during a card game. Conf Proc IEEE Eng Med Biol Soc (2007) 1.04
Gene expression analysis of early and advanced gastric cancers. Oncogene (2007) 1.03
Production of leukotrienes in a model of focal cerebral ischaemia in the rat. Br J Pharmacol (2001) 1.03
Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A(2A) receptor system using positron emission tomography. J Med Chem (2000) 1.03
The appropriate setting of noninvasive pressure support ventilation in stable COPD patients. Chest (2000) 1.03
Investigation on acetylcholine, aspartate, glutamate and GABA extracellular levels from ventral hippocampus during repeated exploratory activity in the rat. Neurochem Res (2003) 1.03
Liver damage in heatstroke and its regression. A biopsy study. Hum Pathol (1972) 1.02
Progressive stroke in pontine infarction. Acta Neurol Scand (2009) 1.02
Effects of morphine on brain and spinal acetylcholine levels and nociceptive threshold in the frog. Brain Res (1974) 1.02
Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol Med (2009) 1.01
Hepatic expression patterns of the large and middle hepatitis B virus surface proteins in viremic and nonviremic chronic hepatitis B. Gastroenterology (1990) 1.01
Interleukin-1beta activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease. Neuroscience (1999) 1.01
Psychiatric disturbances in CADASIL: a brief review. Acta Neurol Scand (2008) 1.01